UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036196
Receipt number R000040765
Scientific Title Verification study of Bowel Movement Improvement by Amazake Consumption
Date of disclosure of the study information 2019/03/15
Last modified on 2020/08/03 17:03:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification study of Bowel Movement Improvement by Amazake Consumption

Acronym

Verification study of Bowel Movement Improvement by Amazake Consumption

Scientific Title

Verification study of Bowel Movement Improvement by Amazake Consumption

Scientific Title:Acronym

Verification study of Bowel Movement Improvement by Amazake Consumption

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification study of Bowel Movement Improvement by Amazake Consumption

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

number of bowel movements per day,
amount of stools, strength of odor, state of the stool, sensation after defecation per bowel movement.

Key secondary outcomes

number of tablets of the magnesium carbonate which ingested per day


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

190g of Amazake using the lees and rice koji, 1 bottle per day

Interventions/Control_2

190g of hot water, 1 cup per day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

1) Person who regular visits at Matsuo Clinic
2) Women with mild constipation who are prescribed magnesium oxide at the age of 20 to 60 years at the time of obtaining informed consent for study participation
3) Person who have be given sufficient explanation about the purpose and contents of this study, has the ability to agree, volunteer for voluntary participation with good understanding, and can consent to this examination in writing
4) Person who can come to the Matsuike Clinic on the designated day and receive an interview
5) Person who were considered appropriate to participate in this study by the study doctor

Key exclusion criteria

1) Person who have symptoms other than mild constipation
2) Person who is no history of visits for the past 3 months
3) Person who have some factor that the examining physician can not judge the affect to the study
4) Person who may be allergic to the test food ingredients
5) Person who regularly drink sweet sake (manufacturer is not matter)
6) Person who plan pregnancy, lactation or pregnancy possibility and pregnancy during the study period
7) Person with alcoholism or other mental disorders
8) Person who may change lifestyle during the examination period (night work, long trips, etc.)
9) Person who are planning to take health functional food or supplement food during the test period
10) Person who received treatment with hospitalization within the past 6 months
11) Person who are currently participating in other clinical trials, or person who have not passed three months after participating in other clinical trials
12) Person who the study doctor judged as inappropriate for this study

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Minoru
Middle name
Last name Morita

Organization

Morinaga & CO., LTD.

Division name

R & D institute

Zip code

230-8514

Address

2-1-1, shimosueyoshi, tsurumi-ku, yokohama, kanagawa, 230-8504 Japan

TEL

045-571-2982

Email

m-morita-je@morinaga.co.jp


Public contact

Name of contact person

1st name Sadao
Middle name
Last name Mori

Organization

Morinaga & CO., LTD.

Division name

R & D institute

Zip code

230-8514

Address

2-1-1, shimosueyoshi, tsurumi-ku, yokohama, kanagawa, 230-8504 Japan

TEL

045-571-2982

Homepage URL


Email

s-mori-ab@morinaga.co.jp


Sponsor or person

Institute

Morinaga & CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

Morinaga & CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Non-Profit Organization MINS Institutional Review Board

Address

5-20-9-401,Mita,Minato-ku,Tokyo,Japan

Tel

03-6416-1868

Email

npo-mins@j-irb.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

松生クリニック(東京都)


Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

38

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 05 Month 17 Day

Date of IRB

2018 Year 05 Month 17 Day

Anticipated trial start date

2018 Year 06 Month 01 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 14 Day

Last modified on

2020 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040765


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name